237 related articles for article (PubMed ID: 33725345)
1. Parkinson's Disease and Impairment in Mitochondrial Metabolism: A Pathognomic Signature.
Das B; Dash SP; Mohanty S; Patel P
Adv Exp Med Biol; 2021; 1286():65-76. PubMed ID: 33725345
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial dysfunction in Parkinson's disease.
Bose A; Beal MF
J Neurochem; 2016 Oct; 139 Suppl 1():216-231. PubMed ID: 27546335
[TBL] [Abstract][Full Text] [Related]
3. Mitochondria, OxPhos, and neurodegeneration: cells are not just running out of gas.
Area-Gomez E; Guardia-Laguarta C; Schon EA; Przedborski S
J Clin Invest; 2019 Jan; 129(1):34-45. PubMed ID: 30601141
[TBL] [Abstract][Full Text] [Related]
4. The unresolved role of mitochondrial DNA in Parkinson's disease: An overview of published studies, their limitations, and future prospects.
Müller-Nedebock AC; Brennan RR; Venter M; Pienaar IS; van der Westhuizen FH; Elson JL; Ross OA; Bardien S
Neurochem Int; 2019 Oct; 129():104495. PubMed ID: 31233840
[TBL] [Abstract][Full Text] [Related]
5. Does mitochondrial DNA play a role in Parkinson's disease? A review of cybrid and other supportive evidence.
Swerdlow RH
Antioxid Redox Signal; 2012 May; 16(9):950-64. PubMed ID: 21338319
[TBL] [Abstract][Full Text] [Related]
6. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.
Büeler H
Exp Neurol; 2009 Aug; 218(2):235-46. PubMed ID: 19303005
[TBL] [Abstract][Full Text] [Related]
7. Immortalized Parkinson's disease lymphocytes have enhanced mitochondrial respiratory activity.
Annesley SJ; Lay ST; De Piazza SW; Sanislav O; Hammersley E; Allan CY; Francione LM; Bui MQ; Chen ZP; Ngoei KR; Tassone F; Kemp BE; Storey E; Evans A; Loesch DZ; Fisher PR
Dis Model Mech; 2016 Nov; 9(11):1295-1305. PubMed ID: 27638668
[TBL] [Abstract][Full Text] [Related]
8. The Role of Mitochondria in Neurodegenerative Diseases: the Lesson from Alzheimer's Disease and Parkinson's Disease.
Monzio Compagnoni G; Di Fonzo A; Corti S; Comi GP; Bresolin N; Masliah E
Mol Neurobiol; 2020 Jul; 57(7):2959-2980. PubMed ID: 32445085
[TBL] [Abstract][Full Text] [Related]
9. Mitochondria: A Therapeutic Target for Parkinson's Disease?
Luo Y; Hoffer A; Hoffer B; Qi X
Int J Mol Sci; 2015 Sep; 16(9):20704-30. PubMed ID: 26340618
[TBL] [Abstract][Full Text] [Related]
10. Neuronal complex I deficiency occurs throughout the Parkinson's disease brain, but is not associated with neurodegeneration or mitochondrial DNA damage.
Flønes IH; Fernandez-Vizarra E; Lykouri M; Brakedal B; Skeie GO; Miletic H; Lilleng PK; Alves G; Tysnes OB; Haugarvoll K; Dölle C; Zeviani M; Tzoulis C
Acta Neuropathol; 2018 Mar; 135(3):409-425. PubMed ID: 29270838
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial Complex I Reversible S-Nitrosation Improves Bioenergetics and Is Protective in Parkinson's Disease.
Milanese C; Tapias V; Gabriels S; Cerri S; Levandis G; Blandini F; Tresini M; Shiva S; Greenamyre JT; Gladwin MT; Mastroberardino PG
Antioxid Redox Signal; 2018 Jan; 28(1):44-61. PubMed ID: 28816057
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial biogenesis: pharmacological approaches.
Valero T
Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial dysfunction in Parkinson's disease.
Winklhofer KF; Haass C
Biochim Biophys Acta; 2010 Jan; 1802(1):29-44. PubMed ID: 19733240
[TBL] [Abstract][Full Text] [Related]
14. The mitochondrial impairment, oxidative stress and neurodegeneration connection: reality or just an attractive hypothesis?
Fukui H; Moraes CT
Trends Neurosci; 2008 May; 31(5):251-6. PubMed ID: 18403030
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial oxidative phosphorylation defects in Parkinson's disease.
Shoffner JM; Watts RL; Juncos JL; Torroni A; Wallace DC
Ann Neurol; 1991 Sep; 30(3):332-9. PubMed ID: 1952821
[TBL] [Abstract][Full Text] [Related]
16. Plausible Role of Mitochondrial DNA Copy Number in Neurodegeneration-a Need for Therapeutic Approach in Parkinson's Disease (PD).
Venkatesan D; Iyer M; Narayanasamy A; Gopalakrishnan AV; Vellingiri B
Mol Neurobiol; 2023 Dec; 60(12):6992-7008. PubMed ID: 37523043
[TBL] [Abstract][Full Text] [Related]
17. Defective mitochondrial protein import contributes to complex I-induced mitochondrial dysfunction and neurodegeneration in Parkinson's disease.
Franco-Iborra S; Cuadros T; Parent A; Romero-Gimenez J; Vila M; Perier C
Cell Death Dis; 2018 Nov; 9(11):1122. PubMed ID: 30405116
[TBL] [Abstract][Full Text] [Related]
18. Re-evaluation of the dysfunction of mitochondrial respiratory chain in skeletal muscle of patients with Parkinson's disease.
Winkler-Stuck K; Kirches E; Mawrin C; Dietzmann K; Lins H; Wallesch CW; Kunz WS; Wiedemann FR
J Neural Transm (Vienna); 2005 Apr; 112(4):499-518. PubMed ID: 15340872
[TBL] [Abstract][Full Text] [Related]
19. Evidence for Compartmentalized Axonal Mitochondrial Biogenesis: Mitochondrial DNA Replication Increases in Distal Axons As an Early Response to Parkinson's Disease-Relevant Stress.
Van Laar VS; Arnold B; Howlett EH; Calderon MJ; St Croix CM; Greenamyre JT; Sanders LH; Berman SB
J Neurosci; 2018 Aug; 38(34):7505-7515. PubMed ID: 30030401
[TBL] [Abstract][Full Text] [Related]
20. Current perspective of mitochondrial biology in Parkinson's disease.
Ammal Kaidery N; Thomas B
Neurochem Int; 2018 Jul; 117():91-113. PubMed ID: 29550604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
